SCHEMBL2466186

SCHEMBL2466186

N#Cc1cccc(-c2ccc(=O)n(Cc3cccc(NC(=O)O)c3)n2)c1

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 14/20 0.60
▸ NQO2 P16083 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2472096 0.91 MET (0.56) MET
SCHEMBL13247059 0.89 MET (0.71) METNQO2
SCHEMBL3111915 0.85 MET (0.58) MET
Hydrochloric Acid SCHEMBL2673060 0.84 HDAC1 (0.58) MET
SCHEMBL2466985 0.84 MET (0.56) MET
SCHEMBL15445160 0.83 MET (0.60) METNQO2
SCHEMBL2672814 0.83 MET (0.75) MET
SCHEMBL2468839 0.82 MET (0.60) MET
SCHEMBL3117528 0.82 MET (0.59) MET
SCHEMBL2470219 0.82 MET (0.62) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173653-B2 Pyridiazinone derivatives for the treatment of tumours MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2012-05-08 — — US claimed
EP-1960370-B1 PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT MERCK PATENT GMBH (DE) 2011-10-05 — — EP claimed
Send feedback